Skip to main content
. 2016 Jun 6;291(31):16038–16047. doi: 10.1074/jbc.M115.710343

TABLE 2.

Oligonucleotides used in this study

Name Oligonucleotide Sequence (5′→3′)a,b Use
For mutagenesis
    OXYR2C206D-F GGAAAAAGAGCATGATCTGACTGAACACGCGGTGTCGG Construction of OxyR2-C206D mutant
    OXYR2C206D-R CCGACACCGCGTGTTCAGTCAGATCATGCTCTTTTTCC
    OXYR2C206S-F GGAAAAAGAGCATAGTCTGACTGAACAC GCGGTGTCGGCC Construction of OxyR2-C206S mutant
    OXYR2C206S-R GGCCGACACCGCGTGTTCAGTCAGACTATGCTCTTTTTCC

For quantitative real-time PCR
    PRX2QRT-F GTTGCTTTCCGTGGCTCTTTCC Expression of prx2
    PRX2QRT-R TACTTCGCCGTGCTTCTGGTG
    OXYR2QRT2-F GCCCAGTCTGAAGCAGTTACACTATC Expression of oxyR2
    OXYR2QRT2-R GAGAGGACAGCCGATCAACTCTTC
    PRX1QRT-F TACCCAGCGGACTTCACTTTCG Expression of prx1
    PRX1QRT-R TGACACTGAGTACACTTCCACACC
    KATGQRT-F CGTTCCGTTTGCAGCAGGTC Expression of katG
    KATGQRT-R CCAGTTGCGGAAGCCATCTG

For DNA footprinting
    PRX2P02-F GCAGAGTAATAAGATAGTGTAACTGC Amplification of prx2 upstream region
    PRX2P02-R CCTACTAGTACCATTTTTTTGCTCC

a The oligonucleotides were designed using the V. vulnificus MO6-24/O genomic sequence (GenBankTM accession numbers CP002469 and CP002470).

b Regions of oligonucleotides not complementary to the corresponding genes are underlined.